X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
female (16) 16
middle aged (14) 14
cardiac & cardiovascular systems (13) 13
male (12) 12
aged (11) 11
index medicus (11) 11
coronary angiography (9) 9
percutaneous coronary intervention (8) 8
risk factors (6) 6
adult (5) 5
chronic total occlusion (5) 5
coronary artery disease (5) 5
follow-up studies (5) 5
heart attacks (5) 5
angioplasty (4) 4
atherosclerosis (4) 4
coronary occlusion - surgery (4) 4
electrocardiography (4) 4
genotype (4) 4
ischemia (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
acute coronary syndromes (3) 3
cardiology (3) 3
cardiovascular (3) 3
chronic disease (3) 3
clopidogrel (3) 3
cohort studies (3) 3
coronary artery disease - genetics (3) 3
coronary heart disease (3) 3
coronary occlusion - diagnosis (3) 3
coronary vessels (3) 3
experience (3) 3
genetic aspects (3) 3
heart attack (3) 3
kaplan-meier estimate (3) 3
myocardial infarction (3) 3
myocardial infarction - etiology (3) 3
myocardial-infarction (3) 3
natriuretic peptides (3) 3
patients (3) 3
platelets (3) 3
prospective studies (3) 3
registries (3) 3
revascularization (3) 3
single-vessel disease (3) 3
stents (3) 3
survival (3) 3
thrombosis (3) 3
time factors (3) 3
adenosine monophosphate - adverse effects (2) 2
adenosine monophosphate - analogs & derivatives (2) 2
adenosine monophosphate - therapeutic use (2) 2
angina (2) 2
angina, stable - diagnosis (2) 2
angina, stable - epidemiology (2) 2
antiplatelet therapy (2) 2
arteries (2) 2
bleeding (2) 2
care and treatment (2) 2
consensus document (2) 2
coronary occlusion - diagnostic imaging (2) 2
coronary occlusion - mortality (2) 2
double-blind method (2) 2
echocardiography (2) 2
elevation myocardial-infarction (2) 2
essential-hypertension (2) 2
gene polymorphism (2) 2
genetic polymorphisms (2) 2
heart-disease (2) 2
hypertensive emergencies (2) 2
hypertensive urgencies (2) 2
incidence (2) 2
infarction (2) 2
mortality (2) 2
multivariate analysis (2) 2
myocardial infarction - epidemiology (2) 2
myocardial infarction - genetics (2) 2
optimal medical therapy (2) 2
outcomes (2) 2
peptidyl-dipeptidase a - genetics (2) 2
percutaneous coronary intervention - adverse effects (2) 2
percutaneous recanalization (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
platelet aggregation inhibitors - therapeutic use (2) 2
poland - epidemiology (2) 2
polymerase chain reaction (2) 2
polymorphism, genetic (2) 2
polymorphism, genetic - genetics (2) 2
prognosis (2) 2
propensity score (2) 2
severe hypertension (2) 2
severity of illness index (2) 2
studies (2) 2
survival rate - trends (2) 2
ticlopidine - adverse effects (2) 2
ticlopidine - analogs & derivatives (2) 2
ticlopidine - therapeutic use (2) 2
trends (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiology journal, ISSN 1897-5593, 09/2018
Red cell distribution width (RDW) in acute heart failure (AHF) is accepted as a prognostic indicator with unclear pathophysiological ties. The aim of this... 
Journal Article
Cardiology journal, ISSN 1897-5593, 03/2018
Coronary artery disease (CAD) affects milions of people and can result in myocardial infarction (MI). Previously, mast cells (MC) have been extensively... 
Journal Article
KARDIOLOGIA POLSKA, ISSN 0022-9032, 2013, Volume 71, Issue 10, pp. 1013 - 1019
Background and aim: The long-term benefit of percutaneous recanalisation of chronic total occlusion (CTO) is still unclear. Given advances in interventional... 
SURVIVAL | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | single-vessel disease | OPTIMAL MEDICAL THERAPY | TRENDS | percutaneous coronary intervention | ANGIOPLASTY | ANGINA | DISEASE | chronic total occlusion | EXPERIENCE | ELEVATION MYOCARDIAL-INFARCTION
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 8/2019, Volume 108, Issue 8, pp. 950 - 962
The tightly packed arrays of polyhedral erythrocytes, polyhedrocytes, formed during thrombus contraction, have been detected in some intracoronary thrombi... 
Myocardial infarction | Scanning electron microscopy | Medicine & Public Health | Polyhedrocytes | Cardiology | Thrombus | Fibrin | Aspirin | Analysis | Clopidogrel | Thrombosis | Heart attack | Blood clot | Polyhedra | Heart attacks | Erythrocytes | Multivariate analysis | Patients | Contraction | Blood clots | Reperfusion | Red blood cells | Ischemia | Perfusion | Electrocardiography | Infarction | Platelets
Journal Article
American Heart Journal, ISSN 0002-8703, 01/2003, Volume 145, Issue 1, pp. 125 - 131
Background There is growing evidence from recent studies that atrial natriuretic peptide (ANP) plays an important part in coronary blood flow regulation and in... 
CARDIAC & CARDIOVASCULAR SYSTEMS | FRAGMENT-LENGTH-POLYMORPHISMS | ANGIOPLASTY | PLASMA-LEVELS | ANGINA | ENDOTHELIAL-CELLS | ATHEROSCLEROSIS | ISCHEMIA | ESSENTIAL-HYPERTENSION | LOCUS | BLOOD-PRESSURE | Influence | Prognosis | Research | Heart diseases | Genetic polymorphisms | Natriuretic peptides
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2003, Volume 88, Issue 2-3, pp. 229 - 237
Background: The Pl allele of the gene encoding for GPIIIa subunit of the platelet membrane receptor glycoprotein (GP) IIb/IIIa has been suggested as a... 
Platelets | Coronary artery disease | Gene polymorphism
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1303 - 1313
This clinical trial compared two antiplatelet regimens during PCI: oral clopidogrel and intravenous cangrelor. As compared with clopidogrel, cangrelor resulted... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | METAANALYSIS | TICAGRELOR | CARDIOVASCULAR EVENTS | ACHIEVE OPTIMAL MANAGEMENT | CLOPIDOGREL PRETREATMENT | PRASUGREL | STANDARD THERAPY | ANTIPLATELET THERAPY | STRATEGIES | Double-Blind Method | Ticlopidine - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Adenosine Monophosphate - analogs & derivatives | Hemorrhage - etiology | Intention to Treat Analysis | Myocardial Ischemia - therapy | Ticlopidine - adverse effects | Female | Aged | Myocardial Ischemia - mortality | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects | Thrombosis - mortality | Platelet Aggregation Inhibitors - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Cangrelor | Angioplasty | Patient outcomes | Product/Service Evaluations | Hemorrhage | Risk factors | Control | Ischemia | Dosage and administration | Drug therapy | Myocardial infarction | Adenosine | Heart attacks | Intravenous administration | Thrombosis | Patients | Bleeding | Dyspnea | Implants | Clopidogrel | Acute coronary syndromes | Respiration
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 08/2015, Volume 86, Issue 2, pp. E49 - E57
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.